Mixed genotype hepatitis C infections and implications for treatment

Hepatology. 2014 Mar;59(3):1209. doi: 10.1002/hep.26544. Epub 2014 Jan 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Drug Resistance, Viral / genetics*
  • Genotype
  • Hepatitis C / drug therapy*
  • Hepatitis C / epidemiology
  • Hepatitis C / genetics*
  • Humans
  • Oligopeptides / therapeutic use*
  • Prevalence
  • Proline / analogs & derivatives*
  • Proline / therapeutic use

Substances

  • Antiviral Agents
  • Oligopeptides
  • telaprevir
  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • Proline